Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation... Show more
A.I.dvisor indicates that over the last year, HIT has been loosely correlated with SMSI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if HIT jumps, then SMSI could also see price increases.
| Ticker / NAME | Correlation To HIT | 1D Price Change % | ||
|---|---|---|---|---|
| HIT | 100% | -2.75% | ||
| SMSI - HIT | 39% Loosely correlated | +0.75% | ||
| DAVE - HIT | 26% Poorly correlated | +2.72% | ||
| RMNI - HIT | 24% Poorly correlated | -1.26% | ||
| WCT - HIT | 23% Poorly correlated | N/A | ||
| CHYM - HIT | 23% Poorly correlated | -1.83% | ||
More | ||||
| Ticker / NAME | Correlation To HIT | 1D Price Change % |
|---|---|---|
| HIT | 100% | -2.75% |
| Technology Services category (399 stocks) | 15% Poorly correlated | +5.32% |
| Packaged Software category (228 stocks) | 10% Poorly correlated | +9.25% |
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HIT advanced for three days, in of 81 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on July 07, 2026. You may want to consider a long position or call options on HIT as a result. In of 25 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.216) is normal, around the industry mean (30.271). P/E Ratio (77.250) is within average values for comparable stocks, (77.945). HIT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.526). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (1.799) is also within normal values, averaging (52.046).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. HIT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.